This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity ...

In A Nutshell A new animal study found that SNAC, the absorption-boosting additive in Rybelsus (oral semaglutide), was linked ...

For many, the results justify the suffering of severe side effects, as one study shows the main motivator behind the ...

The federal government has expanded its drug price negotiation program for seniors in Michigan and beyond, adding more than a ...

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus, a key pipeline drug in its type 2 diabetes franchise. Rybelsus (semaglutide) is the first GLP-1 ...

And, as mentioned, the stock is cheap right now, trading at 13 times earnings, so it looks like a no-brainer. You can buy Novo Nordisk stock for $49 per share, so with $500, you could buy 10 shares.

CEO Sarah Howell talked with Proactive about the company’s second-half performance and its strategic priorities heading into ...

Legal battle between Novo Nordisk and US compounding pharmacy Hims & Hers has fizzled after regulator intervention ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

The prevailing idea has been that a pill is easier to take, it's cheaper and it doesn't require refrigeration like Wegovy and ...

The market for GLP 1 companion foods in Asia faces some major challenges – but big opportunities also await if played right ...